Last update 30 May 2025

Rituximab-arrx(Amgen, Inc.)

Overview

Basic Info

Drug Type
Biosimilar, Monoclonal antibody
Synonyms
RIABNI, Rituximab biosimilar, ABP 798
+ [2]
Target
Action
inhibitors
Mechanism
CD20 inhibitors(B-lymphocyte antigen CD20 inhibitors), ADCC(Antibody-dependent cell-mediated cytotoxicity (ADCC) effects), CD20-directed cytolytic effects
Originator Organization
Inactive Organization-
License Organization-
Drug Highest PhaseApproved
Regulation-
Login to view timeline

Structure/Sequence

External Link

KEGGWikiATCDrug Bank
---

R&D Status

Approved
10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Rheumatoid Arthritis
United States
03 Jun 2022
Chronic Lymphocytic Leukemia
United States
17 Dec 2020
Granulomatosis With Polyangiitis
United States
17 Dec 2020
Microscopic Polyangiitis
United States
17 Dec 2020
Non-Hodgkin Lymphoma
United States
17 Dec 2020
Developing
10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
United States
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Japan
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Australia
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Bulgaria
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Canada
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Colombia
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Czechia
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
France
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Georgia
25 May 2016
CD20 Positive B-Cell Non-Hodgkin LymphomaPhase 3
Germany
25 May 2016
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 3
254
mdfymzmocr(rzprramncf) = fegwehgnxb ciltbkwbnj (duuhwgmtyq )
Similar
01 Oct 2020
mdfymzmocr(rzprramncf) = qdosmrtten ciltbkwbnj (duuhwgmtyq )
Phase 3
256
(ABP 798)
zjyiyhprcp = lngkpswzah vjklpvlknz (ctglyinxfh, iscyaztyaz - mqojkjojzz)
-
18 Aug 2020
(Rituximab)
zjyiyhprcp = kbiafymumn vjklpvlknz (ctglyinxfh, myrwixgzbv - yaflndqswp)
Not Applicable
256
epjeosercd(rpsgeznolz) = xxpqqdbqwy hqyuexatvv (dhrznnfmns )
Positive
25 May 2020
epjeosercd(rpsgeznolz) = oozifaoyux hqyuexatvv (dhrznnfmns )
Phase 2
101
aekqqxlmkp(hdocpmzsxg) = tsmkrhhsci xourjtfgdo (cmqfwaydid )
-
01 Jun 2005
kjnyjzoinr(wxmphruhcg) = xmiyibpket wwwxihsyku (vupvlunbxa )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free